The PROtective Ventilation Using Open Lung Approach Or Not Trial (PROVOLON)

Effects of Open Lung Approach on Intraoperative Respiratory Function and Postoperative Recovery of Patients With Laparoscopic Colorectal Resection

Postoperative Pulmonary Complications (PPC) are very common. It severely affects postoperative recovery, particularly in the abdominal surgery. Patients with laparoscopic resection of colorectal cancer generally have a higher age and decreased lung function reserve. At the same time, they prone to developing atelectasis due to the effects of pneumoperitoneum pressure. Therefore, they are a high-risk group of respiratory insufficiency and PPC.

Mechanical ventilation with a low tidal volume is a routine in clinic nowadays. However, this conventional strategy will also result in atelectasis formation. Therefore, it may deteriorate the vulnerable lung function of patients undergoing laparoscopic resection of colorectal cancer. Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome (ALI/ARDS) could benefit from the "open lung approach", including the use of positive end-expiratory pressure (PEEP) and recruitment maneuvers (RMs). Whether a lung protective mechanical ventilation strategy with medium levels of PEEP and repeated RMs, the "open lung approach", protects against respiratory insufficiency and PPC during laparoscopic resection of colorectal cancer is uncertain. The present study aims at comparing the effects of "open lung approach" mechanical ventilation strategy and conventional mechanical ventilation strategy in PPC, extra-pulmonary complications, length of hospital stay, biomarkers of lung injury and changes of respiratory function in patients undergoing general anesthesia for laparoscopic resection of colorectal cancer.

Study Overview

• Status: Completed
• Conditions: Respiratory Insufficiency; Postoperative Pulmonary Complications
• Intervention / Treatment: Procedure: open lung approach

Detailed Description

1. Sample size calculation, randomization and patients safety. The required sample size is calculated from previous studies on the incidence of postoperative pulmonary complications. A two group chi-square test with a 0.05 two-sided significance level will have 80% power to detect the difference (in primary outcome) between conventional mechanical ventilation strategy (25%) and open lung approach mechanical ventilation strategy (12.5%) when the sample size in each group is 126. In consideration of a 10% loss rate, 280 cases to be included in this trial.

   Research will be carried out in two stages. Completely-randomized design was used in the first stage, and randomized block design in the second stage. The interim analysis will be performed when 100 patients (first stage) have successfully been included and followed-up. The Data Monitoring and Safety Group (DMSG) will provide recommendations about stopping or continuing the trial to the principal investigator. The DMSG will recommend stopping the trial, if significant group-difference in adverse events is found at the interim analysis (p<0.025), or if postoperative pulmonary complications occur more frequently in the intervention group (p<0.025). If the intervention has a strong trend for improving postoperative pulmonary complications (p<0.018) at the first stage, termination of the study is considered.

2. Protocol drop-out. Anesthesiologists are allowed to change the ventilation protocol if there is any concern about patient's safety. The level of PEEP can be modified according to the anesthesiologist in charge if the systolic arterial pressure (SBP)< 80 mmHg and SBP drop ≥30% baseline values for more than 3 minutes despite intravenous fluid infusion and/or start of vasopressors, if dosages of vasopressors are at the highest level tolerated, if new arrhythmias develop which are unresponsive to treatment suggested by the Advanced Cardiac Life Support Guidelines. If there is pneumothorax or hypoxemia (SpO2 < 90% for more than 3 minutes）, if there is need of massive transfusion (>8 units packed red blood cell) to maintain hemoglobin >7 mg/dl, if the duration of pneumoperitoneum is less then 1h or mechanical ventilation time is less then 2h, if there is a surgical complication (such as severe hypercapnia, unexpected conversion to open surgery, unplanned reoperation in 24h after surgery, unplanned ICU admission for surgical reasons) or if patient die during operation, then the patient will be dropped out of the study. All drop-out cases will be included in the safety analysis.

3. Trial settings for intraoperative ventilation. Patients in the conventional mechanical ventilation strategy group will have a tidal volume of 6 to 8 ml per kilogram Predicted Body Weight (PBW), zero PEEP and no recruitment maneuver. Patients in the open lung approach mechanical ventilation strategy group will have a tidal volume of 6 to 8 ml per kilogram PBW, a PEEP level of 6 to 8 cm of water and recruitment maneuvers. Recruitment maneuvers consist of a stepwise increase of tidal volume （as detailed below） and will be applied immediately after tracheal intubation and every 30 min thereafter until the end of surgery.

   In each group, anesthesiologists will be advised to use an inspired oxygen fraction (FIO2) between 0.4 to 0.5 and to maintain oxygen saturation ≥ 92%. The inspiratory to expiratory time ratio will be set at 1:2, with a respiratory rate adjusted to maintain normocapnia (end-tidal carbon dioxide concentration of 30-50 mmHg).

   PBW is calculated according to a predefined formula with: 50 + 0.91 x (centimeters of height - 152.4) for males and 45.5 + 0.91 x (centimeters of height - 152.4) for females. In each group, patients will be ventilated using the volume-controlled ventilation strategy using an anesthesia ventilator: 1. Avance® (Datex-Ohmeda, General Electric, Helsinki, Finland) 2. Tiro® (Dräger, Lübeck, Germany)

4. Recruitment maneuvers.

   Stepwise increase of tidal volume will be used as a method of recruitment maneuvers in this trial. Recruitment maneuvers should not be performed when patients are hemodynamic unstable, as judged by the attending anesthesiologist. Recruitment maneuvers will be performed as follows:

   4-1. Peak inspiratory pressure limit is set at 45 cmH2O. 4-2. Tidal volume is set at 8 ml/kg PBW and respiratory rate at 6 breaths/min, while PEEP is set at 12 cmH2O.

   4-3. Inspiratory to expiratory ratio (I:E) is set at 1:2. 4-4. Tidal volumes are increased in steps of 4 ml/kg PBW until a plateau pressure of 30-35 cmH2O (if tidal volume reach the biggest volume of the ventilator and plateau pressure cannot reach 30-35 cmH2O, then PEEP is set at 16 cmH2O for a plateau pressure of 30-35 cmH2O).

   4-5. Three breaths are administered with a plateau pressure of 30-35 cmH2O. 4-6. Peak inspiratory pressure limit, respiratory rate, I: E, and tidal volume are set back to settings preceding each recruitment maneuver, while maintaining PEEP at 8 cmH2O.

5. Definitions for postoperative complications. All definitions for postoperative complications refer to the IMPROVE trial and the PROVHILO trial.
6. Composition and responsibilities of the DMSG. Members of the DMSG are the management team of anesthesia department in the research hospital. The DMSG will be responsible for safeguarding the interests of trial participants, assessing the safety and efficacy of the intervention during the trial, and for monitoring the overall conduct of the trial. To enhance the integrity of the trial, the DMSG may also formulate recommendations relating to the selection or recruitment of participants, and the procedures of data management and quality control. The DMSG will be advisory to the principal investigator. The principal investigator will be responsible for reviewing the DMSG recommendations, decide whether to continue or terminate the trial, and determine whether changes in trial conduct are required. Any DMSG members who develop significant conflicts of interest during the course of the trial should resign from the DMSG.

7. Data management. Data will be collected and recorded into case report forms (CRFs) by researchers under the supervision of DMSG members. Data manager will scan handwritten data first and then enter data into electronic database. Source data verification will be performed using a cross-check method by researchers when 7-days follow-up have successfully been completed.

   All adverse events, serious adverse events, unexpected or possibly related events will be recorded in the CRF and reported to the DMSG.

8. Statistics. Statisticians will be in blind state for data analysis. Analysis will be by intention-to-treat comparing the primary outcome measure at 7 days in the two groups by chi-squared test (or Fisher's exact test as appropriate). Continuous variables will be compared using the One-way analysis of variance or the Mann-Whitney U test. Categorical variables will be compared using the chi-square test or the Fisher's exact test. The time-to-event curves will be calculated with the use of the Kaplan-Meier method. All analyses will be conducted using the SPSS 16.0 statistical software.

• Study Type: Interventional
• Enrollment (Actual): 280
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Guangdong
    • Guangzhou, Guangdong, China, 510655
      • The Sixth Affiliated Hospital of Sun Yat-sen University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Age ≥ 40 years.
2. Undergo elective laparoscopic resection of colorectal cancer.
3. With an expected duration of pneumoperitoneum ≥1.5h.
4. With a preoperative risk index for pulmonary complications ≥ 2.
5. With no contraindication of epidural anesthesia.
6. Pulse oxygen saturation in air ≥ 92%.
7. And informed consent obtained.

Exclusion Criteria:

1. American Society of Anesthesiologists (ASA) physical status ≥ IV.
2. Body mass index ≥30kg/m2.
3. Duration of mechanical ventilation ≥ 1h within 2 weeks preceding surgery.
4. A history of acute respiratory failure within 1 month preceding surgery.
5. With a sepsis or septic shock or instable hemodynamics.
6. With a progressive neuromuscular illness such as myasthenia gravis.
7. With a epilepsy or schizophrenia or Parkinson's disease.
8. With a severe chronic obstructive pulmonary disease (COPD) or pulmonary bulla.
9. Severe organ dysfunction (acute coronary syndrome, uremia, hepatic encephalopathy, classification of function capacity of the NYHA ≥III, malignant arrhythmia and so on).
10. Coma, severe cognitive deficit, language or hearing impairment who cannot communicate.
11. Not proper controlled hypertension.
12. Involved in other clinical studies or refused to join in the research.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Sequential Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: open lung approach ventilation strategy; Procedure: open lung approach ventilation strategy (OLV). Patients receive volume-controlled mechanical ventilation with a tidal volume of 6 to 8 ml per kilogram of predicted body weight, a PEEP of 6 to 8 cm of water, and recruitment maneuvers repeated every 30 minutes after tracheal intubation.	Procedure: open lung approach; Other Names: open lung strategy
No Intervention: conventional ventilation strategy; Procedure: conventional ventilation strategy (NOLV). Patients receive volume-controlled mechanical ventilation with a tidal volume of 6 to 8 ml per kilogram of predicted body weight, no PEEP and no recruitment maneuver.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Occurrence rate of major pulmonary and extrapulmonary complications	Major pulmonary complications were defined as suspected pneumonia，acute respiratory failure and sustained hypoxia; Major extrapulmonary complications were defined as sepsis, severe sepsis and septic shock or death.	Day 0 to 7 after surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Peak airway Pressure	Peak airway Pressure（Ppeak, cm H2O);	Intraoperative, period of mechanical ventilation
Plateau airway pressure	Plateau airway pressure（Pplat, cm H2O）;	Intraoperative, period of mechanical ventilation
Static lung compliance	Static lung compliance (Csta, ml/cm H2O) = Vt/ (Pplat-PEEP);	Intraoperative, period of mechanical ventilation
Dynamic lung compliance	Dynamic lung compliance (Cdyn , ml/cm H2O)= Vt/ (Ppeak-PEEP);	Intraoperative, period of mechanical ventilation
Arterial partial pressure of oxygen	Arterial partial pressure of oxygen (PaO2, mmHg）; post-anaesthesia care unit (PACU);	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Alveolar-arterial oxygen tension difference	Alveolar-arterial oxygen tension difference (A-aDO2, mmHg）;	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Arterial- alveolar oxygen tension ratio	Alveolar oxygen pressure (PAO2); Arterial- alveolar oxygen tension ratio ( a / A ratio) =PaO2 / PAO2;	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Respiratory index	Fraction of inspired oxygen (FiO2); Respiratory index (RI) = P(A-a)DO2/ FiO2;	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Oxygenation index	Oxygenation index (OI)=PaO2/FiO2;	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Alveolar dead space fraction	Arterial carbon dioxide partial pressure (PaCO2); partial pressure of carbon dioxide in endexpiratory gas (PetCO2); Alveolar dead space fraction (Vd/Vt）=(PaCO2-PetCO2)/ PaCO2;	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Lactic acid	Lactic acid ( LAC, mmol/L);	pre-anesthesia, 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Oxygen extraction ratio	Oxygen content of central venous blood (CvO2); Oxygen content of arterial blood (CaO2); oxygen extraction ratio (O2ER)＝(CaO2-CvO2) /CaO2;	The first stage of the study: 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Central venous blood oxygen saturation	Central venous blood oxygen saturation (ScvO2).	The first stage of the study: 0.5 hour after pneumoperitoneum, 1.5 hours after pneumoperitoneum, 20 minutes after entering PACU
Advanced glycation end products receptor	Advanced glycation end products receptor (RAGE, pg/ml).	Intraoperative (pre-anesthesia, post-operation) and postoperative (postoperative day 3)
S100 beta protein	S100 beta protein （S100β, μg/L）.	Intraoperative (pre-anesthesia, post-operation) and postoperative (postoperative day 3)
Tumor Necrosis Factor alpha	Tumor Necrosis Factor alpha (TNF-α, pg/ml);	Intraoperative (pre-anesthesia, post-operation) and postoperative (postoperative day 3)
Interleukin 6	Interleukin 6 (IL-6, pg/ml).	Intraoperative (pre-anesthesia, post-operation) and postoperative (postoperative day 3)
The occurrence rate of hypoxemia in PACU	The occurrence rate of hypoxemia (PaO2<60 mmhg) in PACU	20 minutes after entering PACU
Length of PACU stay	Length of PACU stay (min);	Though study completion, an average of half an hour.
The recovery time from anesthesia	The recovery time from anesthesia (min).	Though study completion, an average of one hour.
Postoperative pulmonary complications	The incidence of postoperative pulmonary complications based on a PPC scale.	Day 0 to 7 after surgery
Postoperative acute respiratory failure	Occurrence rate of acute respiratory failure (SpO2< 90% or PaO2<60mmhg);	Day 0 to 7 after surgery
Postoperative suspected pneumonia	Occurrence rate of postoperative pneumonia;	Day 0 to 7 after surgery
Pulse oximetry less than 92%	Occurrence rate of saturation of pulse oximetry less than 92%;	Day 0 to 7 after surgery
Sustained hypoxia	Occurrence rate of sustained hypoxia	Day 0 to 7 after surgery
Saturation of pulse oximetry	Saturation of pulse oximetry (SpO2);	Day 0 to 7 after surgery
Occurrence rate of intervention-related adverse events	Intervention-related adverse events including: rescue therapy for desaturation, potentially harmful hypotension, pneumothorax, vasoactive drugs needed.	Intraoperative, period of mechanical ventilation
Postoperative delirium	Postoperative delirium will be estimated by a scale called Confusion Assessment Method-ICU.	Day 1 to 3 after surgery
Occurrence rate of related complications	Related complications including: the systemic inflammatory response syndrome (SIRS), acute myocardial infarction (AMI), Acute hepatic and renal insufficiency; surgical complications including intraabdominal abscess, anastomotic leakage.	Day 0 to 7 after surgery
Unplanned reoperation after 24h	Unplanned reoperation after 24h (operation not caused by bleeding in 24h).	Up to 30 days after surgery
Postoperative hospital stay	Postoperative hospital stay.	Up to 30 days after surgery
Lung recruitment maneuver systolic blood pressure changes	Systolic blood pressure (SBP, mmHg);	The first stage of the study: intraoperative, when lung recruitment maneuver is operated.
Lung recruitment maneuver related diastolic blood pressure changes	Diastolic blood pressure (DBP, mmHg);	The first stage of the study: intraoperative, when lung recruitment maneuver is operated.
Lung recruitment maneuver related mean arterial pressure changes	Mean arterial pressure (MBP, mmHg); heart rate (HR, bpm).	The first stage of the study: intraoperative, when lung recruitment maneuver is operated.
Lung recruitment maneuver related heart rate changes	Heart rate (HR, bpm).	The first stage of the study: intraoperative, when lung recruitment maneuver is operated.
Death from any cause.	Death from any cause 30 days after surgery.	Up to 30 days after surgery
Unplanned admission to ICU	Unplanned admission to ICU (not caused by bleeding in 24h).	Up to 30 days after surgery
Impaired oxygenation	PaO2/FIO2 ≤ 300 mmHg	before anesthesia induction, 0.5 h and 1.5 h after pneumoperitoneum induction, and 20 min after postanesthesia care unit (PACU) admission

Collaborators and Investigators

• Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
• Investigators: Principal Investigator: Hong Li, MD, Sixth Affiliated Hospital, Sun Yat-sen University

Publications and helpful links

General Publications

• Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B, Verzilli D, Leone M, De Jong A, Bazin JE, Pereira B, Jaber S; IMPROVE Study Group. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013 Aug 1;369(5):428-37. doi: 10.1056/NEJMoa1301082.
• Fernandez-Bustamante A, Frendl G, Sprung J, Kor DJ, Subramaniam B, Martinez Ruiz R, Lee JW, Henderson WG, Moss A, Mehdiratta N, Colwell MM, Bartels K, Kolodzie K, Giquel J, Vidal Melo MF. Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators. JAMA Surg. 2017 Feb 1;152(2):157-166. doi: 10.1001/jamasurg.2016.4065.
• Rothen HU, Sporre B, Engberg G, Wegenius G, Reber A, Hedenstierna G. Prevention of atelectasis during general anaesthesia. Lancet. 1995 Jun 3;345(8962):1387-91. doi: 10.1016/s0140-6736(95)92595-3.
• Smetana GW. Preoperative pulmonary evaluation. N Engl J Med. 1999 Mar 25;340(12):937-44. doi: 10.1056/NEJM199903253401207. No abstract available.
• Brooks-Brunn JA. Predictors of postoperative pulmonary complications following abdominal surgery. Chest. 1997 Mar;111(3):564-71. doi: 10.1378/chest.111.3.564.
• Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003 Jun 11;289(22):2983-91. doi: 10.1001/jama.289.22.2983.
• Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707. No abstract available. Erratum In: N Engl J Med. 2014 Apr 24;370(17):1668-9.
• Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981 Jun;123(6):659-64. doi: 10.1164/arrd.1981.123.6.659.
• Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, Hedenstierna G, Freden F. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009 Nov;111(5):979-87. doi: 10.1097/ALN.0b013e3181b87edb.
• Serpa Neto A, Cardoso SO, Manetta JA, Pereira VG, Esposito DC, Pasqualucci Mde O, Damasceno MC, Schultz MJ. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012 Oct 24;308(16):1651-9. doi: 10.1001/jama.2012.13730.
• Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005 Apr;102(4):838-54. doi: 10.1097/00000542-200504000-00021.
• Guay J, Ochroch EA. Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury. Cochrane Database Syst Rev. 2015 Dec 7;(12):CD011151. doi: 10.1002/14651858.CD011151.pub2.
• Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801.
• PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology; Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014 Aug 9;384(9942):495-503. doi: 10.1016/S0140-6736(14)60416-5. Epub 2014 Jun 2.
• Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, Rana R, St Sauver JL, Lymp JF, Afessa B, Hubmayr RD. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med. 2004 Sep;32(9):1817-24. doi: 10.1097/01.ccm.0000133019.52531.30.
• Lee WL, Detsky AS, Stewart TE. Lung-protective mechanical ventilation strategies in ARDS. Intensive Care Med. 2000 Aug;26(8):1151-5. doi: 10.1007/s001340051332. No abstract available.
• Wanderer JP, Blum JM, Ehrenfeld JM. Intraoperative low-tidal-volume ventilation. N Engl J Med. 2013 Nov 7;369(19):1861. doi: 10.1056/NEJMc1311316. No abstract available.
• Cox PN, Bryan AC. Small tidal volumes and the open-lung approach. Crit Care Med. 2001 Apr;29(4):915. doi: 10.1097/00003246-200104000-00056. No abstract available.
• Rothen HU, Sporre B, Engberg G, Wegenius G, Hedenstierna G. Re-expansion of atelectasis during general anaesthesia: a computed tomography study. Br J Anaesth. 1993 Dec;71(6):788-95. doi: 10.1093/bja/71.6.788.
• Jaber S, Coisel Y, Chanques G, Futier E, Constantin JM, Michelet P, Beaussier M, Lefrant JY, Allaouchiche B, Capdevila X, Marret E. A multicentre observational study of intra-operative ventilatory management during general anaesthesia: tidal volumes and relation to body weight. Anaesthesia. 2012 Sep;67(9):999-1008. doi: 10.1111/j.1365-2044.2012.07218.x. Epub 2012 Jun 18.
• Hess DR, Kondili D, Burns E, Bittner EA, Schmidt UH. A 5-year observational study of lung-protective ventilation in the operating room: a single-center experience. J Crit Care. 2013 Aug;28(4):533.e9-15. doi: 10.1016/j.jcrc.2012.11.014. Epub 2013 Jan 29.
• Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014 Jul;113(1):97-108. doi: 10.1093/bja/aeu054. Epub 2014 Mar 12.
• Takahata O, Kunisawa T, Nagashima M, Mamiya K, Sakurai K, Fujita S, Fujimoto K, Iwasaki H. Effect of age on pulmonary gas exchange during laparoscopy in the Trendelenburg lithotomy position. Acta Anaesthesiol Scand. 2007 Jul;51(6):687-92. doi: 10.1111/j.1399-6576.2007.01311.x. Epub 2007 Apr 26.
• Retamal J, Borges JB, Bruhn A, Cao X, Feinstein R, Hedenstierna G, Johansson S, Suarez-Sipmann F, Larsson A. High respiratory rate is associated with early reduction of lung edema clearance in an experimental model of ARDS. Acta Anaesthesiol Scand. 2016 Jan;60(1):79-92. doi: 10.1111/aas.12596. Epub 2015 Aug 10.
• Arozullah AM, Khuri SF, Henderson WG, Daley J; Participants in the National Veterans Affairs Surgical Quality Improvement Program. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med. 2001 Nov 20;135(10):847-57. doi: 10.7326/0003-4819-135-10-200111200-00005.
• Guldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, Rocco PR, Schultz MJ, Pelosi P, Gama de Abreu M. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology. 2015 Sep;123(3):692-713. doi: 10.1097/ALN.0000000000000754.
• Citerio G, Pesenti A, Latini R, Masson S, Barlera S, Gaspari F, Franzosi MG; NeuroMorfeo Study Group. A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy. Eur J Anaesthesiol. 2012 Aug;29(8):371-9. doi: 10.1097/EJA.0b013e32835422db.
• Hemmes SN, Severgnini P, Jaber S, Canet J, Wrigge H, Hiesmayr M, Tschernko EM, Hollmann MW, Binnekade JM, Hedenstierna G, Putensen C, de Abreu MG, Pelosi P, Schultz MJ. Rationale and study design of PROVHILO - a worldwide multicenter randomized controlled trial on protective ventilation during general anesthesia for open abdominal surgery. Trials. 2011 May 6;12:111. doi: 10.1186/1745-6215-12-111.
• Jiang SP, Li ZY, Huang LW, Zhang W, Lu ZQ, Zheng ZY. Multivariate analysis of the risk for pulmonary complication after gastrointestinal surgery. World J Gastroenterol. 2005 Jun 28;11(24):3735-41. doi: 10.3748/wjg.v11.i24.3735.
• Xu T, Bo L, Wang J, Zhao Z, Xu Z, Deng X, Zhu W. Risk factors for early postoperative cognitive dysfunction after non-coronary bypass surgery in Chinese population. J Cardiothorac Surg. 2013 Nov 1;8:204. doi: 10.1186/1749-8090-8-204.
• Jabaudon M, Futier E, Roszyk L, Sapin V, Pereira B, Constantin JM. Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury. Respirology. 2015 Oct;20(7):1131-8. doi: 10.1111/resp.12583. Epub 2015 Jun 29.
• Li H, Zheng ZN, Zhang NR, Guo J, Wang K, Wang W, Li LG, Jin J, Tang J, Liao YJ, Jin SQ. Intra-operative open-lung ventilatory strategy reduces postoperative complications after laparoscopic colorectal cancer resection: A randomised controlled trial. Eur J Anaesthesiol. 2021 Oct 1;38(10):1042-1051. doi: 10.1097/EJA.0000000000001580.
• Li H, Guo J, Wang K, Zhang NR, Zheng ZN, Jin SQ. [Effect of open-lung ventilation strategy on oxygenation-impairment during laparoscopic colorectal cancer resection]. Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1081-1087. doi: 10.3760/cma.j.issn.441530-20191209-00507. Chinese.

Study record dates

Study Major Dates

• Study Start (Actual): January 12, 2017
• Primary Completion (Actual): September 20, 2018
• Study Completion (Actual): October 12, 2018

Study Registration Dates

• First Submitted: April 21, 2017
• First Submitted That Met QC Criteria: May 17, 2017
• First Posted (Actual): May 19, 2017

Study Record Updates

• Last Update Posted (Actual): December 3, 2019
• Last Update Submitted That Met QC Criteria: December 1, 2019
• Last Verified: December 1, 2019

More Information

Terms related to this study

• Keywords: laparoscopic resection of colorectal cancer; open lung approach
• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency
• Other Study ID Numbers: 2017ZSLYEC-002

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No